| The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer RM Bremnes, LT Busund, TL Kilvær, S Andersen, E Richardsen, ... Journal of Thoracic Oncology 11 (6), 789-800, 2016 | 465 | 2016 |
| Prognostic value of macrophage phenotypes in resectable non–small cell lung cancer assessed by multiplex immunohistochemistry M Rakaee, LTR Busund, S Jamaly, EE Paulsen, E Richardsen, ... Neoplasia 21 (3), 282-293, 2019 | 128 | 2019 |
| Assessing PDL-1 and PD-1 in non–small cell lung cancer: a novel immunoscore approach EE Paulsen, TK Kilvaer, MR Khanehkenari, S Al-Saad, SM Hald, ... Clinical lung cancer 18 (2), 220-233. e8, 2017 | 93 | 2017 |
| CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases EE Paulsen, TK Kilvaer, M Rakaee, E Richardsen, SM Hald, S Andersen, ... Cancer Immunology, Immunotherapy 66, 1449-1461, 2017 | 89 | 2017 |
| The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort N Ness, S Andersen, MR Khanehkenari, CV Nordbakken, A Valkov, ... Oncotarget 8 (16), 26789, 2017 | 85 | 2017 |
| Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers TK Kilvaer, MR Khanehkenari, T Hellevik, S Al-Saad, EE Paulsen, ... PloS one 10 (8), e0134965, 2015 | 81 | 2015 |
| High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence Y Nordby, E Richardsen, M Rakaee, N Ness, T Donnem, HRH Patel, ... Scientific reports 7 (1), 43378, 2017 | 79 | 2017 |
| CD45RO+ Memory T Lymphocytes—a candidate marker for TNM-immunoscore in squamous non–small cell lung cancer EE Paulsen, T Kilvaer, MR Khanehkenari, RJ Maurseth, S Al-Saad, ... Neoplasia 17 (11), 839-848, 2015 | 71 | 2015 |
| Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer M Rakaee, LT Busund, EE Paulsen, E Richardsen, S Al-Saad, ... Oncotarget 7 (44), 72184, 2016 | 66 | 2016 |
| Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer M Rakaee, TK Kilvaer, SM Dalen, E Richardsen, EE Paulsen, SM Hald, ... Human pathology 79, 188-198, 2018 | 63 | 2018 |
| LAG-3 in non–small-cell lung cancer: expression in primary tumors and metastatic lymph nodes is associated with improved survival SM Hald, M Rakaee, I Martinez, E Richardsen, S Al-Saad, EE Paulsen, ... Clinical lung cancer 19 (3), 249-259. e2, 2018 | 62 | 2018 |
| Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort E Richardsen, S Andersen, S Al-Saad, M Rakaee, Y Nordby, MI Pedersen, ... PloS one 12 (11), e0186852, 2017 | 57 | 2017 |
| Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer K Skjefstad, T Grindstad, MR Khanehkenari, E Richardsen, T Donnem, ... Steroids 113, 5-13, 2016 | 57 | 2016 |
| Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer M Rakaee, TK Kilvaer, S Jamaly, T Berg, EE Paulsen, M Berglund, ... British Journal of Cancer 124 (10), 1680-1689, 2021 | 51 | 2021 |
| MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer E Richardsen, S Andersen, C Melbø-Jørgensen, M Rakaee, N Ness, ... Scientific reports 9 (1), 386, 2019 | 51 | 2019 |
| Association of machine learning–based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC M Rakaee, E Adib, B Ricciuti, LM Sholl, W Shi, JV Alessi, A Cortellini, ... JAMA oncology 9 (1), 51-60, 2023 | 49 | 2023 |
| Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis S Jamaly, M Rakaee, R Abdi, GC Tsokos, KA Fenton Autoimmunity reviews 20 (12), 102980, 2021 | 47 | 2021 |
| Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer TK Kilvaer, M Rakaee, T Hellevik, A Østman, C Strell, RM Bremnes, ... PLoS One 13 (2), e0192157, 2018 | 47 | 2018 |
| Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression T Grindstad, E Richardsen, S Andersen, K Skjefstad, ... Scientific reports 8 (1), 11358, 2018 | 45 | 2018 |
| Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome T Grindstad, K Skjefstad, S Andersen, N Ness, Y Nordby, S Al-Saad, ... Scientific reports 6 (1), 33114, 2016 | 43 | 2016 |
David J. KwiatkowskiProfessor of Medicine, Harvard Medical School在 rics.bwh.harvard.edu 的电子邮件经过验证
